Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Divine Skin, a biotechnology company engaged in the development of topical therapies and over-the-counter drugs, is planning to introduce an over-the-counter (OTC) pain reliever drug.
Subscribe to our email newsletter
The company intends to start shipping upon final authorization by the Drug Enforcement Administration.
Divine Skin chairman and CEO Daniel Khesin said since Divine Skin focuses on underserved and niche categories, of course their pain medication will offer patients some benefits that competitors don’t.
"The product will give better pain relief, with a safety profile similar to that of Advil," Khesin said.